Mapping the human memory B cell and serum neutralizing antibody responses to dengue virus serotype 4 infection and vaccination

Usha K. Nivarthi, Nurgun Kose, Gopal Sapparapu, Douglas Widman, Emily Gallichotte, Jennifer M. Pfaff, Benjamin J. Doranz, Daniela Weiskopf, Alessandro Sette, Anna P Durbin, Steve S. Whitehead, Ralph Baric, James E. Crowe, Aravinda M. de Silva

Research output: Contribution to journalArticle

Abstract

The four dengue virus (DENV) serotypes are mosquito-borne flaviviruses responsible for dengue fever and dengue hemorrhagic fever. People exposed to DENV develop antibodies (Abs) that strongly neutralize the serotype responsible for infection. Historically, infection with DENV serotype 4 (DENV4) has been less common and less studied than infections with the other three serotypes. However, DENV4 has been responsible for recent large and sustained epidemics in Asia and Latin America. The neutralizing antibody responses and the epitopes targeted against DENV4 have not been characterized in human infection. In this study, we mapped and characterized epitopes on DENV4 recognized by neutralizing antibodies in people previously exposed to DENV4 infections or to a live attenuated DENV4 vaccine. To study the fine specificity of DENV4 neutralizing human antibodies, B cells from two people exposed to DENV4 were immortalized and screened to identify DENV-specific clones. Two human monoclonal antibodies (MAbs) that neutralized DENV4 were isolated, and their epitopes were finely mapped using recombinant viruses and alanine scan mutation array techniques. Both antibodies bound to quaternary structure epitopes near the hinge region between envelope protein domain I (EDI) and EDII. In parallel, to characterize the serum neutralizing antibody responses, convalescence-phase serum samples from people previously exposed to primary DENV4 natural infections or a monovalent DENV4 vaccine were analyzed. Natural infection and vaccination also induced serum-neutralizing antibodies that targeted similar epitope domains at the EDI/II hinge region. These studies defined a target of neutralizing antigenic site on DENV4 targeted by human antibodies following natural infection or vaccination.

Original languageEnglish (US)
Article numbere02041-16
JournalJournal of Virology
Volume91
Issue number5
DOIs
StatePublished - 2017

Keywords

  • Antibody responses
  • Dengue virus serotype 4
  • Epitope
  • Human
  • Infection
  • Memory B cells
  • Neutralization
  • Vaccination

ASJC Scopus subject areas

  • Immunology
  • Virology

Fingerprint Dive into the research topics of 'Mapping the human memory B cell and serum neutralizing antibody responses to dengue virus serotype 4 infection and vaccination'. Together they form a unique fingerprint.

  • Cite this

    Nivarthi, U. K., Kose, N., Sapparapu, G., Widman, D., Gallichotte, E., Pfaff, J. M., Doranz, B. J., Weiskopf, D., Sette, A., Durbin, A. P., Whitehead, S. S., Baric, R., Crowe, J. E., & de Silva, A. M. (2017). Mapping the human memory B cell and serum neutralizing antibody responses to dengue virus serotype 4 infection and vaccination. Journal of Virology, 91(5), [e02041-16]. https://doi.org/10.1128/JVI.02041-16